Coverage summary
| Indication | Coverage |
|---|---|
| Wegovy (weight loss) | No |
| Zepbound (weight loss) | Limited |
| Ozempic or Mounjaro (type 2 diabetes) | Yes |
If New Jersey Medicaid says no, two cash programs to check.
No insurance needed.
- Strut Health$149 a month, with auto-refillcompounded semaglutideCheck price →You pick Weight Loss, then a five-minute online visit
- Shed$199 a month30% off first month with code Shed10compounded semaglutideCheck price →A health form first, then you choose your plan
Cheapest GLP-1 without insurance compares the three cash routes, and cheapest GLP-1 in New Jersey prices each drug that ships there.
A clinical trial costs nothing, and nobody checks your income.
Prior-authorization criteria
These rules come from the state preferred drug list (PDL), the list of drugs New Jersey Medicaid has agreed to pay for. Prior authorization means your doctor asks the plan to approve the drug before the pharmacy fills it. Nearly every state covers the diabetes path that way.
| Criterion | Value |
|---|---|
| How hard the approval is | Hard |
| BMI threshold (weight-loss path) | No bar to meet: New Jersey excludes weight-loss agents by rule. |
| Comorbidity required | No |
| What you pay when a GLP-1 is covered | Nothing on NJ FamilyCare Plan A, Plan B or the Alternative Benefit Plan. |
| Who does pay | Plan C and Plan D children under 19, at $1 generic and $5 brand. |
| Last PDL update reviewed | August 2025 |
Copay read from N.J.A.C. 10:51, Pharmaceutical Services Manual (effective July 24, 2023), read September 16, 2026 and the NJ FamilyCare managed care contract (effective January 2026), read September 16, 2026.
If the plan denies it, the appeal letter templates cover the reasons plans give and what to send back.
What NJ FamilyCare paid for GLP-1s
NJ FamilyCare reported 32,999 GLP-1 prescriptions to CMS in 2025's last quarter and paid pharmacies $34.2 million.
Counts Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda and Rybelsus, in fee-for-service and managed care, before rebates. CMS blanks its smallest rows, so the real figures are higher. Source: CMS State Drug Utilization Data.
What this means in practice
NJ FamilyCare covers GLP-1s only for FDA-approved uses other than weight loss: Wegovy for cardiovascular disease, Zepbound for sleep apnea, plus pediatric EPSDT cases. A weight-loss expansion exists only as a state budget study so far.
Managed-care organizations in New Jersey
New Jersey Medicaid pays private health plans, called managed-care organizations or MCOs, to run its coverage. An MCO has to cover at least what the state list covers and can add rules of its own. Check your own plan's current rules before you send anything in.
- Horizon NJ Health
- UnitedHealthcare Community Plan NJ
- WellCare NJ (Centene)
- Aetna Better Health of New Jersey
- Fidelis Care NJ
Cash-pay alternatives if Medicaid does not cover you
New Jersey covers Wegovy for cardiovascular disease, not for weight. If you have had a heart attack or stroke, that is the strongest path here.
If you end up paying cash, the GLP-1 cost guide has what each cash route costs, from the compounded floor to the manufacturer-direct brand prices. Federal law bars manufacturer savings cards for anyone on Medicaid.
If a supply gap rather than cost is blocking your refill, the GLP-1 shortage tracker shows which formulations the FDA lists as in shortage now. And if you are 65 or older and also have Medicare, the senior GLP-1 hub lays out the Medicare coverage paths for dual-eligible patients.
For the full cash-pay picture specific to New Jersey, see the cheapest GLP-1 in New Jersey guide.
12 GLP-1 clinical trials are recruiting in New Jersey, and a study supplies its own study medication. Every site is listed on GLP-1 clinical trials in New Jersey.
New Jersey Medicaid GLP-1 FAQ
Does NJ FamilyCare (New Jersey Medicaid) cover Wegovy for weight loss?
Does NJ FamilyCare (New Jersey Medicaid) cover Zepbound for weight loss?
Does NJ FamilyCare (New Jersey Medicaid) cover Ozempic or Mounjaro for diabetes?
What if NJ FamilyCare (New Jersey Medicaid) does not cover my GLP-1?
Other state Medicaid pages
See the full 51-state coverage table for the side-by-side view across every US state.
How we built this page
Compiled from each state Medicaid's published preferred drug list, PA criteria and PDL committee minutes. State Medicaid programs are not federally required to cover obesity drugs; the diabetes indication is covered nearly everywhere with PA. State-level data is point-in-time and shifts each PDL cycle. Always verify with your state Medicaid plan before relying on this page.
Checked August 24, 2026. We check each state Medicaid PDL and PA criteria quarterly. If you have recently had a different experience with New Jersey Medicaid, email hello@glpchart.com with the details and we will check it.